Verastem Oncology: Verastem Oncology Announces $75 million Private Placement
BOSTON-(BUSINESS WIRE)-Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today... Read MoreThe post Verastem Oncology Announces $75 million Private Placement appeared first on citybiz.
Read full article »
Verastem Oncology is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Read more